Abstract:Background: By modulating the oxygen partial pressure of alveolar epithelial cells, the granulocyte-macrophage colony-stimulating factor (GM-CSF) can stimulate and enhance the innate immune response in the lungs. This study aimed to investigate the therapeutic efficacy of rhGM-CSF in patients suffering from extrapulmonary-induced acute respiratory distress syndrome (ARDS). Methods: A randomized, double-blind, placebo-controlled clinical trial was conducted between February 2018 to July 2019, in which 66 sepsis patients with ARDS were recruited. The study randomly allocated the patients into 2 groups: an experimental group (34 cases receiving rhGM-CSF) and a control group (32 cases receiving placebo). The changes in lung function were assessed using the scores of PaO2/FIO2 ratio, acute physiology and chronic health evaluation II, sequential organ failure assessment, and lung injury. Additionally, the study analyzed the levels of inflammatory cells, HLA-DR (%), high mobility group protein B1 (HMGB-1) (ng/mL), tumor necrosis factor-alpha (pg/mL), IL-6 (pg/mL), and GM-CSF (pg/mL) in both blood and bronchoalveolar lavage fluid. Results: The study results revealed that the experimental group significantly enhanced their pulmonary function compared to the control group. Moreover, the experimental group demonstrated higher levels of inflammatory cells and HLA-DR, whereas levels of HMGB-1 and tumor necrosis factor-alpha were lower in blood (P < .05, respectively). In addition, the experimental group displayed a higher alternatively activated cell ratio and GM-CSF levels in bronchoalveolar lavage fluid (both P < .05); while HMGB-1 levels were significantly reduced (P < .05). However, no notable difference observed in mortality between the 2 groups (P > .05). Conclusions: Administering rhGM-CSF to ARDS patients improves lung function and decreases blood inflammation. Nonetheless, while this treatment demonstrates efficacy in reducing these parameters, it does not significantly impact the incidence of ventilator-associated pneumonia or 28-day mortality in ARDS patients.

The Progress of Granulocyte-Macrophage Colony-Stimulating Factor on the Mechanism of Acute Lung Injury

Progress in Alveolar Macrophages

Clinical study of rhGM-CSF for the treatment of pulmonary exogenous acute respiratory distress syndrome by modulating alveolar macrophage subtypes: A randomized controlled trial

Progress in the Studies of Granulocyte/Macrophage Colony-Stimulating Factor Regulating the Angiogenesis and Wound Healing

Granulocyte-macrophage colony-stimulating factor: Conductor of the wound healing orchestra?

Granolocyte-macrophage Clony-Stimulating Factor and Neuroprotection

Effect of granulocyte colony stimulating factor in immunomodulation and role in intestinal immune homeostasis

Pathogenesis of acute lung injury: pre-B-cell colony-enhancing factor is a new potential target

Abstract PR566

[Effect of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor on Wound Healing in Patients with Deep Partial Thickness Burn].

The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis

GM-CSF in inflammation

Intracellular GM-CSF signaling in circulating monocytes, monocyte-derived macrophages, and human lung macrophages

The Stimulation of Macrophages by Systematical Administration of GM-CSF Can Accelerate Adult Wound Healing Process

[Effect of Granulocyte Colony-Stimulating Factor on Immunological Regulation and Its Application in Allogenic Hematopoietic Stem Cell Transplantation].

Changes of the peripheral CD34 positive cells and inflammatory factors levels after using GM-CSF in patients with acute myocardial infarction

Therapeutic Effect and Safety of Granulocyte Colony-Stimulating Factor Therapy for Acute-On-Chronic Liver Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of GM-CSF on the Stem Cells Mobilization and Plasma C-reactive Protein Levels in Patients with Acute Myocardial Infarction.

G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

S1924 Impact of Granulocyte Colony Stimulating Factor on the Survival of Patients With Decompensated Cirrhosis and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-analysis